在癌症中准Hippo路径:脏毒性作为TEAD抑制剂的类效应?
Sayantanee Paul1, Jessica Sims2, Trang Pham1
1Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080.
Trends in cancer
|November 9, 2024
概括
河马通路和TEAD抑制剂在癌症治疗中表现有前途,但需要进一步的安全性研究. 本综述考察了它们在癌症和脏发育中的作用,以获得更好的临床转化.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 河马通路对于癌症的发展和对向治疗的耐药性至关重要.
- TEAD抑制剂正在成为一类有前途的抗癌药物,有几种正在临床试验中.
- 了解河马通路在发育中的作用对于评估潜在的毒性至关重要.
研究的目的:
- 审查河马通路在各种癌症中的参与.
- 讨论TEAD抑制剂在瘤学中的治疗潜力.
- 评估Hippo通路抑制的安全性,重点关注脏效应,并指导临床翻译.
主要方法:
- 临床前和临床研究的文献综述.
- 分析河马通路在癌症发病和耐药性方面的作用.
- 检查Hippo通路在脏发育和平衡中的功能.
主要成果:
- 河马通路调节细胞增殖,生存和组织生长,使其成为癌症的关键目标.
- 在临床前的癌症模型中,TEAD抑制剂已经证明有效.
- 初步数据表明,与Hippo路径抑制相关的潜在脏副作用需要仔细评估.
结论:
- TEAD 抑制剂代表了癌症治疗的重大进展.
- 需要进行进一步的研究,以充分了解和减轻Hippo途径向药物的潜在脏相关毒性.
- 优化治疗策略对于最大限度地使患者受益并确保这些新型药物的长期安全至关重要.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.7K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.6K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K